Public Company News
TI advances driver assistance technology to more accurately monitor blind spots and efficiently navigate turns and corners to safely avoid collisions
HANOI, Vietnam, Jan. 11, 2021 /PRNewswire/ -- In an effort to move autonomous driving and vehicle safety forward, Texas Instruments (TI) (Nasdaq: TXN) today announced an expansion of its automotive offerings that can help automakers improve how advanced driver assistance systems (ADAS) sense ob...
LTI Partners with Securonix & Snowflake to Strengthen Cybersecurity Offerings
MUMBAI, India, Jan. 11, 2022 /PRNewswire/ -- Larsen & Toubro Infotech
XCMG Launches First Silk Road E-Commerce Station, XCMG-PNG, Offering One-Stop Equipment Purchases in South Pacific Regions
XUZHOU, China, Jan. 11, 2022 /PRNewswire/ -- XCMG Papua New Guinea (XCMG-PNG), the first Silk Road E-Commerce Station by XCMG (SZ:000425), is officially online to provide one-stop service experience for construction machinery customers and users in the South Pacific and surrounding regions withPa...
Pfizer Drives Cultural Change in Sustainable and Accessible Data with MicroStrategy
SINGAPORE, Jan. 11, 2022 /PRNewswire/ -- MicroStrategy
Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of ASC42, An In-House Developed, Best-in-Class FXR Agonist for Chronic Hepatitis B Indication
HANGZHOU, China and SHAOXING, China, Jan. 11, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first patient in the Phase II clinical trial of ASC42 for chronic hepatitis B (CHB) indication. The Phase II clinical trial (ClinicalTrials.gov Identifier: NCT051...
Xaxis Uses IAS's Context Control Targeting to Raise Awareness for a Fashion Brand
TAIPEI, Jan. 11, 2022 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a global leader in digital media quality, and Xaxis, GroupM's outcome media specialist, used Context Control Targeting to increase campaign performance, website traffic, and brand awareness for a major fashion retailer, all ...
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
SEATTLE, SAN FRANCISCO, SAN JOSE, Calif., NANJING, China, SUZHOU, China and SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmace...
SKF acquires additive manufacturing company
GOTHENBURG, Sweden, Jan. 11, 2022 /PRNewswire/ -- SKF has completed the acquisition of Laser Cladding Venture n.v. (LCV), an additive manufacturing company based inBelgium. LCV is a niche engineering start-up specialized in various additive manufacturing technologies and processes, which can be ...
Buybacks of series B shares in AB Electrolux during week 01, 2022
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- During the period January 03 - January 07, 2022 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 342,312 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimize ...
Everest Medicines Will Participate in a Clinical Trial with Gilead and MSD to Evaluate Trodelvy® in Combination with KEYTRUDA® (pembrolizumab) in First-Line Metastatic Non-Small Cell Lung Cancer
SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Everest Medicines
Invitation to Autoliv's Q4, 2021 Earnings Call
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- Autoliv Inc., plans to publish its Financial Report for the fourth quarter 2021 onFriday, January 28, 2022 at 12:00 Central European Time (CET). The report will be available at www.autoliv.com In addition, a teleconference will take place the same day. T...
Bigtincan Announces Bigtincan for Salesforce on Salesforce AppExchange, the World's Leading Enterprise Cloud Marketplace
Bigtincan's customers can now benefit from a powerful recommendation engine WALTHAM, Mass., Jan. 10, 2022 /PRNewswire/ -- Bigtincan® (ASX:BTH), a global leader in sales enablement automation, today announced the general availability of Bigtincan for Salesforce on Salesforce AppExchange, empoweri...
Clinical study on Bactiguard's endotracheal tube now published - shows significant reduction of ventilator-associated pneumonia
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well renowned journal Annals of Intensive Care. The study shows a 53% reduction of ventilator-associated pneumonia with Bactiguard's endotracheal tube. It was presented for th...
Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business
BOSTON and LAUSANNE, Switzerland, Jan. 10, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced key additions to their leadership team with the hiring of Peter Casasanto as Chief B...
Clarivate Announces Change in Leadership Structure
LONDON, Jan. 10, 2022 /PRNewswire/ -- Clarivate plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that as part of its One Clarivate Vision to put even greater focus on its customers and solutions, effectiveFebruar...
China Telecom's Annual Report Received 20 Gold Awards in Total Together with Two Grand Awards in International ARC Awards
HONG KONG, Jan. 10, 2022 /PRNewswire/ -- China Telecom Corporation Limited ("China Telecom" or "the Company"; HKEx: 00728; SSE: 601728) is pleased to announce that the print and online versions of its 2020 Annual Report " Digitalising the Future" received 11 gold awards in total in this year's In...
GoodWe rebrands, highlighting the role of smart tech in transforming the future of energy
SUZHOU, China, Jan. 10, 2022 /PRNewswire/ -- GoodWe has refreshed its brand in line with the evolution of the global new energy space, emphasizing on collaboration and digitalization. At the core of this new brand identity is GoodWe's commitment to harnessing smart tech to drive the global energy...
Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma Report also examines key therapeutic development areas to watch including mRNA, CRISPR, AI-driven drug discovery and more LONDON, Jan. 10, 2022 /...
JW Therapeutics Announces Two Appointments to Strengthen R&D Capability and Pipeline Building
SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, recently announced the appointments of Dr.Shaun Paul Cordoba as Chief Scientific Officer (...
Ascletis Announces U.S. IND Filing for In-House Developed Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors
HANGZHOU, China and SHAOXING, China, Jan. 10, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) announces today the filing of the U.S. Investigational New Drug (IND) application for in-house developed oral PD-L1 small molecule inhibitor, ASC61, for the treatment of advanced solid tumors. AS...
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 312 media titles]
2026-10-13 10:00Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 293 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 282 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 280 media titles]
2026-10-15 12:59DayOne Upsizes Malaysia Financing to US$7.2 Billion; Total Billings Surpass 1GW and Bookings Reach 2.3GW
[Picked up by 270 media titles]
2026-10-14 18:01